Loading…
Reported covered position: Legislative Counsel, Sen. Ken Salazar
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Source: Senate LDA
| COALITION ON HEALTH CARE |
| 9 |
| 2011–2013 |
| NOVO NORDISK, INC. | 8 | 2011–2012 |
| MEDCO HEALTH SOLUTIONS INC | 5 | 2011–2012 |
| AETNA, INC. | 2 | 2012 |
| SANOFI PASTEUR | 1 | 2011 |
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
Safeguarding America's Pharmaceuticals Act of 2013
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues; H.R. 2725, Food and Drug Administration Safety Over Sequestion Act of 2013.
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
Medicare Better Health Rewards Program Act of 2013
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
H.R. 1851/S. 881, Family Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
Pharmaceutical Quality, Security, and Accountability Act
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
S. 959, Pharmaceutical Quality, Security and Accountability Act; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; H.R. 3204, the Drug Quality and Security Act.
Family Act of 2011 (S. 965 and H.R. 3522 in the 112th Congress).
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Telehealth Promotion Act of 2012
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: DLA PIPER LLP (US)
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Counterfeit Drug Penalty Enhancement Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Counterfeit Drug Penalty Enhancement Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; FDA-related safety issues.
Food and Drug Administration Reform Act of 2012
Client: PFIZER, INC. · Firm: DLA PIPER LLP (US)
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
To extend the temporary suspension of duty on mixtures of indoxacarb and inert ingredients.
Client: EMD SERONO, INC. · Firm: DLA PIPER LLP (US)
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act; Issues related to supply chain safety.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013. H.R. 3204, the Drug Quality and Security Act.
H.R. 1851/S. 881, Family Act of 2013.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · third_quarter · Q3
IRC Section 833(b) tax provisions.
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues; H.R. 2725, Food and Drug Administration Safety Over Sequestion Act of 2013.
Issues related to Medicare/Medicaid reimbursements; S. 1228, Medicare Better Health Records Program Act of 2013.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law 111-148, provisions related to the employer mandate. Telehealth Promotion Act of 2012 (H.R. 6719 in the 112th Congress). Implementation of Public Law No. 112-240, provisions on Commission on Long-Term Care.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
H.R. 1851/S. 881, Family Act of 2013.
S. 959, Pharmaceutical Quality, Security and Accountability Act. H.R. 1919, Safeguarding America's Pharmaceutical Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2013 · first_quarter · 1A
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to supply chain safety.
Issues related to Medicare/Medicaid reimbursements.
Family Act of 2011 (S. 965 and H.R. 3522 in the 112th Congress).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Implementation of Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act; FDA-related safety issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · first_quarter · Q1
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · fourth_quarter · 4A
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; FDA-related safety issues.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · fourth_quarter · Q4
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act; Issues related to supply chain safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
H.R. 5657, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · third_quarter · Q3
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; Care coordination initiatives; health information technology; Million Hearts Initiative and wellness initiatives.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
AETNA, INC. via DLA PIPER LLP (US)
2012 · first_quarter · RR
Health care reform issues.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; S. 3187, The Food and Drug Administration Safety and Innovation Act; H.R. 5651, The Food and Drug Administration Reform Act of 2012; H.R. 3668, The Counterfeit Drug Penalty Enhancement Act of 2012.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · second_quarter · Q2
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.
H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Reauthorization of the Prescription Drug User Fee Act.
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid drug rebates.
Prescription Drug User Fee Act; Reauthorization.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of Public Law No. 111-148, issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2012 · first_quarter · Q1
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · RR
Health care financing.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Issues related to Medicare/Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · fourth_quarter · Q4
S. 965, Family Act of 2011. H.R. 3522, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
S. 965, Family Act of 2011.
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Issues related to Medicare and Medicaid drug rebates.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
SANOFI PASTEUR via DLA PIPER LLP (US)
2011 · third_quarter · Q3
Pandemic influenza, vaccine-related issues; H.Res. 295, promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
S. 965, Family Act of 2011.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Implementation of Public Law No. 111-148.
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; Prescription Drug User Fee Act (PDUFA).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MEDCO HEALTH SOLUTIONS, INC. via DLA PIPER LLP (US)
2011 · second_quarter · RR
Issues related to Medicare/Medicaid reimbursements.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2011 · second_quarter · RR
Implementation of Public Law No. 111-148
EMD SERONO, INC. via DLA PIPER LLP (US)
2011 · second_quarter · RR
S. 965 - The Family Act of 2011
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · second_quarter · Q2
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Implementation of Public Law No. 111-148, provisions affecting community health centers.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · first_quarter · Q1
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2011 · first_quarter · RR
Issues related to Medicare and Medicaid reimbursement.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2011 · first_quarter · RR
Issues related to the prevention and treatment of diabeties; Implementation of Public Law No. 111-148.
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2011 · first_quarter · RR
Implementation of Public Law No. 111-148. Medicare and Medicaid reimbursement for end-stage renal disease patients.
Implementation of Public Law No. 111-148. Medicare and Medicaid reimbursement for end-stage renal disease patients.
PFIZER, INC. via DLA PIPER LLP (US)
2011 · first_quarter · RR
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry.
NATIONAL ASSOCIATION OF COMMUNITY HEALTH CENTERS via DLA PIPER LLP (US)
2011 · first_quarter · RR
Implementation of Public Law No. 111-148, provisions affecting community health centers.